| Tretinoin | Approved Investigational Nutraceutical | SOCS2 | 8835 |
upregulated | Tretinoin results in increased expression of SOCS2 mRNA | 12q | |
| Tretinoin | Approved Investigational Nutraceutical | SOCS3 | 9021 |
upregulated | Tretinoin results in increased expression of SOCS3 mRNA | 17q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SOCS5 | 9655 |
upregulated | Tretinoin results in increased expression of SOCS5 mRNA | 2p21 | |
| Tretinoin | Approved Investigational Nutraceutical | SOD1 | 6647 |
downregulated | Tretinoin results in decreased expression of SOD1 mRNA | 21q22.11 | |
| Tretinoin | Approved Investigational Nutraceutical | SOD2 | 6648 |
upregulated | Tretinoin results in increased expression of SOD2 mRNA | 6q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SOD3 | 6649 |
downregulated | Tretinoin results in decreased expression of SOD3 mRNA | 4p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SOGA3 | 387104 |
downregulated | Tretinoin results in decreased expression of SOGA3 mRNA | 6q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SOHLH1 | 402381 |
upregulated | Tretinoin results in increased expression of SOHLH1 mRNA | 9q34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SON | 6651 |
downregulated | Tretinoin results in decreased expression of SON mRNA | 21q22.11 | |
| Tretinoin | Approved Investigational Nutraceutical | SORBS2 | 8470 |
downregulated | Tretinoin results in decreased expression of SORBS2 mRNA | 4q35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SORCS1 | 114815 |
upregulated | Tretinoin results in increased expression of SORCS1 mRNA | 10q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SORCS2 | 57537 |
upregulated | Tretinoin results in increased expression of SORCS2 mRNA | 4p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SORL1 | 6653 |
upregulated | Tretinoin results in increased expression of SORL1 mRNA | 11q24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SOSTDC1 | 25928 |
upregulated | Tretinoin results in increased expression of SOSTDC1 mRNA | 7p21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX1 | 6656 |
downregulated | Tretinoin results in decreased expression of SOX1 mRNA | 13q34 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX12 | 6666 |
downregulated | Tretinoin results in decreased expression of SOX12 mRNA | 20p13 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX13 | 9580 |
downregulated | Tretinoin results in decreased expression of SOX13 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX2 | 6657 |
downregulated | Tretinoin results in decreased expression of SOX2 mRNA | 3q26.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX2-OT | 347689 |
downregulated | Tretinoin results in decreased expression of SOX2-OT mRNA | 3q26.33 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX3 | 6658 |
downregulated | Tretinoin results in decreased expression of SOX3 mRNA | Xq27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX3 | 6658 |
upregulated | Tretinoin results in increased expression of SOX3 mRNA | Xq27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX4 | 6659 |
upregulated | Tretinoin results in increased expression of SOX4 mRNA | 6p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX5 | 6660 |
downregulated | Tretinoin results in decreased expression of SOX5 mRNA | 12p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX5 | 6660 |
upregulated | Tretinoin results in increased expression of SOX5 mRNA | 12p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SOX6 | 55553 |
downregulated | Tretinoin results in decreased expression of SOX6 mRNA | 11p15.3 | |